FEATURED ARTICLES
Discover four mistakes biotechs often make in haste (and how to avoid them) as they hurry through clinical trial contracting on the path to commercilization.
-
Seema Verma On Huge Opportunities In Healthcare And Life Sciences
The former industry regulator and now Oracle EVP and GM for health and life sciences discusses the most promising solutions to the industries’ biggest challenges.
-
2 Ways To Encourage Clinical Trial Investor Funding
Consider these two promising funding models that balance risk with reward: trial-specific fundraising and staged funding release.
-
The Key Differences Between Expanded Access Programs And Investigator Sponsored Trials
Expanded access programs (EAPs) and investigator sponsored trials (ISTs) play significant roles. While both aim to provide patients with access to investigational therapies, they operate under distinct frameworks and serve different purposes. Understanding their differences from traditional clinical trials is crucial from an investigational medicine product and supply chain perspective.